Interactions between cancer cells and the microvasculature: a rate-regulator for metastasis
- PMID: 2465861
- DOI: 10.1007/BF01787020
Interactions between cancer cells and the microvasculature: a rate-regulator for metastasis
Abstract
Hematogenous metastasis is a major consideration in the staging, treatment and prognosis of patients with cancer. Key events affecting hematogeneous metastasis occur in the microvasculature. This is a brief, selective review of some interactions involving cancer cells and the microvasculature in pathologic sequence, specifically: (1) intravasation of cancer cells; (2) the arrest of circulating cancer cells in the microvasculature; (3) cancer cell trauma associated with arrest; (4) microvascular trauma; (5) the inflammatory; and (6) the hemostatic coagulative responses associated with arrest, and finally (7) angiogenesis, leading to tumor vascularization. The evidence shows that through a series of complex interactions with cancer cells, the microvasculature acts as a rate-regulator for the metastatic process, in addition to providing routes for cancer cell dissemination and arrest sites for cancer cell emboli.
Similar articles
-
Interactions of cancer cells with the microvasculature during metastasis.FASEB J. 1988 Jan;2(1):12-21. doi: 10.1096/fasebj.2.1.3275560. FASEB J. 1988. PMID: 3275560 Review.
-
Biomechanical interactions of cancer cells with the microvasculature during metastasis.Cell Biophys. 1989 Apr;14(2):187-215. doi: 10.1007/BF02797133. Cell Biophys. 1989. PMID: 2472208 Review.
-
Biomechanical interactions of cancer cells with the microvasculature during hematogenous metastasis.Cancer Metastasis Rev. 1992 Nov;11(3-4):227-35. doi: 10.1007/BF01307179. Cancer Metastasis Rev. 1992. PMID: 1423815 Review.
-
Inhibition of the arrest of hematogenously disseminated tumor cells.Cancer Metastasis Rev. 1983;2(3):223-37. doi: 10.1007/BF00048479. Cancer Metastasis Rev. 1983. PMID: 6367967 Review.
-
Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium.Cancer Res. 2003 Jul 1;63(13):3805-11. Cancer Res. 2003. PMID: 12839977
Cited by
-
Deformation-driven, lethal damage to cancer cells. Its contribution to metastatic inefficiency.Cell Biophys. 1991 Apr;18(2):73-9. doi: 10.1007/BF02989807. Cell Biophys. 1991. PMID: 1726527 Review.
-
Interaction of tumor cells with vascular endothelia: role of platelet-activating factor.Clin Exp Metastasis. 2000;18(1):89-96. doi: 10.1023/a:1026548700247. Clin Exp Metastasis. 2000. PMID: 11206844
-
Lung metastases after liver resection or cryotherapy for hepatic metastasis from colorectal cancer--there is a difference!HPB (Oxford). 2006;8(2):124-31. doi: 10.1080/13651820500274911. HPB (Oxford). 2006. PMID: 18333260 Free PMC article.
-
BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process.Am J Pathol. 2008 Mar;172(3):809-17. doi: 10.2353/ajpath.2008.070772. Epub 2008 Feb 14. Am J Pathol. 2008. PMID: 18276787 Free PMC article.
-
Protein kinase C-dependent effects of 12(S)-HETE on endothelial cell vitronectin receptor and fibronectin receptor.J Cell Biol. 1993 May;121(3):689-704. doi: 10.1083/jcb.121.3.689. J Cell Biol. 1993. PMID: 7683691 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources